Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic kidney Diseases

• Published in: International journal of molecular sciences Vol. 21; no. 5; p. 1647
• Main Authors: Noh, Mi Ra, Jang, Hee-Seong, Kim, Jinu, Padanilam, Babu J
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 28.02.2020; MDPI AG
• Subjects: acute kidney injury; adrenergic receptor; chronic kidney disease; norepinephrine; Review; sympathetic nervous system; norepinephrine; adrenergic receptor; chronic kidney disease; acute kidney injury; sympathetic nervous system
• ISSN: 1422-0067; 1422-0067
• DOI: 10.3390/ijms21051647

The kidney is innervated by afferent sensory and efferent sympathetic nerve fibers. Norepinephrine (NE) is the primary neurotransmitter for post-ganglionic sympathetic adrenergic nerves, and its signaling, regulated through adrenergic receptors (AR), modulates renal function and pathophysiology under disease conditions. Renal sympathetic overactivity and increased NE level are commonly seen in chronic kidney disease (CKD) and are critical factors in the progression of renal disease. Blockade of sympathetic nerve-derived signaling by renal denervation or AR blockade in clinical and experimental studies demonstrates that renal nerves and its downstream signaling contribute to progression of acute kidney injury (AKI) to CKD and fibrogenesis. This review summarizes our current knowledge of the role of renal sympathetic nerve and adrenergic receptors in AKI, AKI to CKD transition and CKDand provides new insights into the therapeutic potential of intervening in its signaling pathways.